People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology, Other Health Care, Other Technology, Pharma, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Delfi Diagnostics, Inc. | — | Biotechnology | Series D+ | $365.9M | $235.9M | 2022 |
| NeuroPace Inc | — | Other Health Care | Series C | $208.6M | $1.5B | 2020 |
| Turnstone Biologics Corp. | — | Biotechnology | Series C | $122.1M | $2.2B | 2019 |
| Dimension Therapeutics, Inc. | — | Other Technology | Series C | $94.5M | $2.0B | 2015 |
| CHARM Therapeutics Inc. | — | Pharma | Series B | $87.0M | $77.3M | 2025 |
| Sientra, Inc. | — | Other Health Care | Series C | $65.0M | $1.5B | 2012 |
| Avitide, Inc. | — | Pharmaceuticals | Series A | $40.9M | $309.7M | 2014 |
| Gelesis Inc | — | Biotechnology | Series B | $37.7M | $1.3B | 2011 |
| Symbiomix Therapeutics, LLC | — | Pharmaceuticals | Series B | $25.5M | $204.0M | 2013 |
| Aer Therapeutics, Inc. | — | Biotechnology | Series B | $20.9M | $28.0M | 2022 |
| Attenua, Inc. | — | Pharmaceuticals | Series B | $15.2M | $517.0M | 2018 |
| Meves Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $10.9M | $337.8M | 2018 |
Rishi Gupta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rishi Gupta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ben Auspitz | 2 | 9 |
| Thomas Beck | 2 | 7 |
| Michael Ross | 1 | 18 |
| Ajay Royan | 1 | 13 |
| Jerel Davis | 1 | 13 |
| Nael Kassar | 1 | 11 |
| Elon Boms | 1 | 10 |
| Jonathan Silverstein | 1 | 10 |
| Tim Shannon | 1 | 9 |
| Errik Anderson | 1 | 8 |
| Briggs Morrison | 1 | 8 |
| James Blair | 1 | 8 |
| Annalisa Jenkins | 1 | 8 |
| Greg Garfield | 1 | 8 |
| Greg Yap | 1 | 8 |
| Gary Glick | 1 | 7 |
| David Fischell | 1 | 6 |
| Christy Shaffer | 1 | 6 |
| Ian Ratcliffe | 1 | 6 |
| Klaus Veitinger | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.